Industry Symposia

Industry Symposia

LOOK BACK, THINK FORWARD: ADVANCING PID PATIENT CARE OVER THE YEARS

Takeda Logo

SYMPOSIUM IS ORGANISED AND SUPPORTED BY Takeda

Wednesday, September 18 | 16:00 – 17:30 | Gold Hall
Chair: Mikko Seppänen (Finland)

16:00-16:10

Welcome and introduction
Mikko Seppänen (Finland)

16:10-16:30

Stop the delay – simplifying diagnosis in PID
Mikko Seppänen (Finland)

16:30-16:50

Growing up with PID – smoothing the transition from pediatrics to adult care
Eline Visser (Netherlands)

16:50-17:10

Comprehensive care – managing PID and cancer
Silvia Sánchez-Ramón (Spain)

17:10-17:25

Q&A

17:25-17:30

Summary and close
Mikko Seppänen (Finland)

INFECTIONS AND SECONDARY IMMUNODEFICIENCY IN HEMATOLOGICAL CANCER: IDENTIFYING PATIENTS AT RISK

CSL

SYMPOSIUM IS ORGANISED AND SUPPORTED BY CSL Behring

Thursday, September 19 | 12:45 – 14:15 | Copper Hall
Chair: Donald Vinh (Canada)

12:45-12:55

INTRODUCTION
Donald Vinh (Canada)

12:55–13:15

HEMATOLOGICAL MALIGNANCIES AND SID:  WHAT DO WE KNOW?
Donald Vinh (Canada)

13:15-13:35

RISK FACTORS FOR INFECTIONS IN SID: WHAT ARE WE MISSING? RESULTS OF A NEW STUDY
Stephen Jolles (UK)

13:35-13:55

HOW TO MANAGE THE UNIQUE INFECTION RISK PROFILE IN HEMATOLOGICAL MALIGNANCIES
B. Douglas, Smith (US)

13:55-14:15

PATIENT CASE & ROUNDTABLE DISCUSSION
Donald Vinh (Canada), Stephen Jolles (UK) and Douglas Smith (US)

14:15

MEETING CLOSE
Donald Vinh (Canada)

Lunch will be provided

THE CHANGING PICTURE OF SECONDARY IMMUNE DEFICIENCY IN HAEMATOLOGICAL MALIGNANCIES

SYMPOSIUM IS ORGANISED AND SUPPORTTED BY Octapharma

Friday, September 20 | 12:45 – 14:15 | Silver Hall
Chair: Stephen Jolles (UK)

12:45-12:50

Welcome and introduction
Stephen Jolles (UK)

12:50-13:10

What underpins the growth in secondary antibody deficiency?
Stephen Jolles (UK)

13:10-13:30

CD19 CAR-T cells – Implications for the management of secondary immune deficiency
Michael Albert (Germany)

13:30-13:50

Recommendations for the management of secondary hypogammaglobulinaemia
Fabian Hauck (Germany)

 

13:50-14:10

CLL – An illustrative case of a complex secondary immune deficiency
Jean-François Viallard (France)

14:10-14:15

Discussion and closing remarks
All

 

Lunch will be provided